news & events

Check out what we’ve been up to and where can we connect!


Remdisivir superior to standard care for hospitalized adults with COVID-19: Final ACTT-1 results published in NEJM

October 8, 2020
Final results of the Adaptive COVID-19 Treatment Trial (ACTT)-1 investigating remdesivir for the treatment of COVID-19 in hospitalized adults with evidence of lower respiratory tract involvement have been published in the New England Journal of Medicine (NEJM). Of the FHI Clinical study team members, Danielle Fisher, Clinical Research Project Manager, and Wendi McDonald, Associate Project Manager, are listed on the manuscript for their contributions to the study.

Read More »


ASTMH 2020 Annual Meeting

November 15-19, 2020
Attending the ASTMH 2020 Annual Meeting? Schedule a meeting with an FHI Clinical team member who will be in attendance at the event or stop by our booth

Read More »

Clinical Trials of the Future

September 29, 2020
Register for this virtual plenary session at World Vaccine Congress Washington where panelists will discuss how to incorporate innovation into vaccine clinical trials, including how to apply information from the field to ongoing and future vaccine trials, use of real-world evidence for vaccine efficacy and regulatory perspectives in new development areas.

Read More »

World Vaccine Congress

September 28-October 1, 2020
Attending World Vaccine Congress Washington? Register for events at which our industry experts will be presenting or schedule a meeting with a team member who will be in attendance at the event.

Read More »

Strengthening the African Clinical Trials Regulatory and Ethics Environment

September 16, 2020
In this webinar hosted by the African Academy of Sciences Clinical Trials Community (CTC), a range of stakeholders will discuss the importance of robust and efficient regulatory and ethics bodies for the clinical trial landscape, role of the WHO African Vaccine Regulatory Forum (AVAREF), and role of the CTC platform in enhancing collaborations and promoting efficiency through shared regulatory and ethics information.

Read More »